TW
GSK icon

TrinityPoint Wealth’s GSK GSK Stock Holding History

TrinityPoint Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-6,374
Closed -$300K – 231
2020
Q3 		$300K Buy
6,374
+4
+0.1% +$200 0.08% 178
2020
Q2 		$325K Sell
6,370
-169
-3% -$8.67K 0.1% 160
2020
Q1 		$310K Sell
6,539
-94
-1% -$5.01K 0.12% 156
2019
Q4 		$390K Sell
6,633
-73
-1% -$4.06K 0.13% 146
2019
Q3 		$377K Sell
6,706
-3,652
-35% -$188K 0.13% 140
2019
Q2 		$536K Sell
10,358
-9,183
-47% -$461K 0.26% 94
2019
Q1 		$1.02M Buy
19,541
+172
+0.9% +$8.6K 0.5% 57
2018
Q4 		$925K Buy
+19,369
New +$954K 0.57% 49

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

TrinityPoint Wealth's GSK Position: Q4 2020 in Review

TrinityPoint Wealth sold out of GSK (GSK) in Q4 2020, closing a stake of 6,374 shares — an estimated $300K sold.

TrinityPoint Wealth first reported a position in GSK in Q4 2018 and held it in 8 quarters. The position peaked at $1.02M in Q1 2019. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

  • TrinityPoint Wealth reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
  • TrinityPoint Wealth sold 6,374 GSK shares in Q4 2020, an estimated $300K.
  • TrinityPoint Wealth first reported a position in GSK in Q4 2018 and held it in 8 quarters.
  • TrinityPoint Wealth's GSK position peaked at $1.02M in Q1 2019.
  • 818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on TrinityPoint Wealth's 13F filing for Q4 2020, filed 10 Feb 2021.